This case series evaluates survival and radiographic and serologic measures of responses associated with administration of FOLFIRINOX or gemcitabine plus nab-paclitaxel as first-line chemotherapy in patients with previously untreated localized pancreatic ductal adenocarcinoma.
This meta-analysis evaluates the ratio of heart failure (HF) to all-cause hospitalizations in randomized clinical trials, whether differences in all-cause hospitalization can be inferred from…
This cohort study assesses incidence of primary invasive cutaneous malignant melanoma and mortality trends in Sweden, focusing on the population younger than the mean age…
This cross-sectional study examines whether federally qualified health centers in Florida offer eye care services, where the services are available, what services are being offered,…
This longitudinal cohort study using data from the Avon Longitudinal Study of Parents and Children (ALSPAC) examines trajectories of inflammation in childhood and their associations…
This cohort study investigates associations between a composite score for guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction at the time of…
This nonrandomized clinical trial examines the safety and efficacy of guanylate cyclase-C (GCC) chimeric antigen receptor T-cell therapy in patients with metastatic colorectal cancer.
Application Deadline: January 4, 2021. The Morris Fishbein Fellowship in Medical Editing is a unique one-year fellowship opportunity offered by JAMA to introduce physicians to…
This viewpoint discusses the benefits of the exposome and the reasons it should be used to understand pediatric health disparities.
This JAMA Patient Page outlines 7 strategies that patients can use to respond to high prescription drug costs in the US.
This Viewpoint presents an updated scientific approach applied to the foundational framework of the Haddon Matrix for injury prevention to reduce firearm injuries and deaths…
